NeuroMetrix (NSDQ:NURO) shares jumped yesterday after the company announced a $21 million private placement and said its Quell pain relief device is on the shelves at 1,000 retail drug stores.
The private placement of 21,300 Series C shares at $1,000 apiece went to an institutional investor dedicated to backing healthcare companies, Waltham, Mass.-based NeuroMetrix said. The offering also included warrants for 11.8 million shares at a $1.69 exercise price, the company said.
